in

Divi’s Laboratories Q1 results: Net profit rises 13% YoY to Rs 557 cr; forex gains at Rs 20 cr

Getty Images
The numbers were boosted by forex gains of Rs 20 crore against Rs 5 crore gain in the corresponding quarter last year. (Representative image)
NEW DELHI: Divi’s Laboratories on Saturday reported a 13.21 per cent year-on-year rise in consolidated profit after tax (PAT) at Rs 557 crore for June quarter compared with Rs 492 crore in the same quarter last year.

Total income for the quarter rose 14.24 per cent YoY to Rs 1,997 crore compared with Rs 1,748 crore in the corresponding last year. The company continued to have near normal operations during the quarter complying to all Covid-19 protocols, the company said in a BSE filing.

The numbers were boosted by forex gains of Rs 20 crore against Rs 5 crore gain in the corresponding quarter last year.

Profit before tax (PBT) for the quarter came in at Rs 814 crore against Rs 661 crore in the year-ago quarter.

On a standalone basis, PAT came in at Rs 552 crore against Rs 492 crore YoY. Total revenue was up at Rs 1,986 crore compared with Rs 1,728 crore YoY.

The company is engaged in the manufacture of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients. The scrip closed at Rs 4,915.90 on BSE, down 0.15 per cent.

(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

/disclaimer.cms?msid=5766568potime:4


Source: Divi’s Laboratories Q1 results: Net profit rises 13% YoY to Rs 557 cr; forex gains at Rs 20 cr

What do you think?

Nuvoco Vistas garners Rs 1,500 cr from anchor investors ahead of IPO

Dog owners and animal charities criticise service stations for not allowing dogs inside